The expression of CD109 has also been reported in cancer stem-like cells/cancer-initiating cells (CSCs/CICs) in the epithelioid sarcoma cell line ESX, and was found to be associated with poor prognosis in patients with soft tissue sarcoma [39]. Here, CD109 is linked to cancer.